These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3517405)

  • 1. [In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
    Kumasaka Y; Nakahata H; Hirai Y; Imamura K; Takebe K; Suzuki I; Senda H
    Jpn J Antibiot; 1986 Jan; 39(1):154-8. PubMed ID: 3517405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefmetazole: clinical evaluation of efficacy and safety in Japan.
    Shimada J; Hayashi Y; Nakamura K
    Drugs Exp Clin Res; 1985; 11(3):181-94. PubMed ID: 3869805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of cefotetan in an experimental local infection with facultative and obligate anaerobes in granuloma pouches in rats.
    Saito M; Saito T; Yano K; Shibata K; Nishino T; Tanino T
    J Antimicrob Chemother; 1984 Feb; 13(2):133-42. PubMed ID: 6368517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Double-blind comparison of cefotetan and cefmetazole in complex urinary tract infections].
    Kamidono S; Ishigami J; Arakawa S; Umezu K; Ohmori H; Ishito N; Nihira H; Ishino T; Kurokawa K; Fujimura N
    Jpn J Antibiot; 1983 Jun; 36(6):1325-53. PubMed ID: 6361310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphological alterations in Escherichia coli and Serratia marcescens induced by cefotetan (author's transl)].
    Saito M; Saito T; Yano K
    Jpn J Antibiot; 1982 Mar; 35(3):850-5. PubMed ID: 7047794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of the MIC of cefotetan against freshly isolated gram-negative bacilli].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1989 Nov; 42(11):2363-76. PubMed ID: 2621779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility of clinical isolates to aztreonam].
    Asari S; Horikawa M; Tsukamoto H; Kouda K; Hayashi C; Miyai K
    Jpn J Antibiot; 1987 Jul; 40(7):1317-31. PubMed ID: 3479624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo activity of cefbuperazone (T-1982) against various experimental infections in mice.
    Suzuki I; Senda H; Yokota T
    J Antibiot (Tokyo); 1985 Feb; 38(2):249-58. PubMed ID: 3997670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative double-blind study of cefotetan and cefmetazole in patients with purulent peritonitis].
    Tanimura H; Hikasa Y; Kobayashi N; Kato H; Sekiya T; Sato T; Saito T; Yoshida K; Huang W; Hashino H; Nakamura M; Deguchi K
    Jpn J Antibiot; 1983 Feb; 36(2):369-90. PubMed ID: 6343664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
    Saito M; Azuma K; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Oct; 36(10):2833-43. PubMed ID: 6325746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antibacterial activity of cefodizime, a new cephalosporin antibiotic.
    Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
    Jpn J Antibiot; 1984 Jul; 37(7):1306-12. PubMed ID: 6092740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of a new cephamycin, MT-141, in compromised mice.
    Kawaharajo K; Shitoh K; Niizeki M; Murata S; Sekizawa Y
    J Antibiot (Tokyo); 1984 Dec; 37(12):1703-11. PubMed ID: 6441793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cefotetan, a new cephamycin antibiotic: in vitro and in vivo antibacterial activities (author's transl)].
    Yano K; Suzaki K; Saito M; Toda M; Naito S; Ohmi Y
    Jpn J Antibiot; 1982 Feb; 35(2):438-59. PubMed ID: 6953260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of third-generation cephalosporins in human blood.
    Shah PM; Jaenisch E
    Clin Ther; 1983; 6(1):72-8. PubMed ID: 6325006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double-blind clinical study on cefotetan and cefmetazole in treating respiratory tract infections].
    Jpn J Antibiot; 1983 Feb; 36(2):316-68. PubMed ID: 6343663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
    Isono M; Kawashima K; Yamada N; Aoki M; Kobayashi T; Sawa K; Watanabe K; Ueno K
    Jpn J Antibiot; 1982 Jul; 35(7):1667-72. PubMed ID: 6757469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental and clinical evaluation of T-1982 (cefbuperazone) in the field of obstetrics and gynecology].
    Ninomiya K; Makino S; Hasegawa Y; Yoshimoto T
    Jpn J Antibiot; 1983 May; 36(5):986-93. PubMed ID: 6352989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory and clinical studies of flomoxef].
    Nozue N; Ueda Y; Haga T; Muraoka A; Ono Y; Nishiya H; Miyashita H
    Jpn J Antibiot; 1987 Oct; 40(10):1774-86. PubMed ID: 3327964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.